6:32 AM ET
10-Q
Financial Results
iSpecimen Q3 2026 Results: Net Loss of $2.21M, Loss Narrows
For the nine months ended September 30, 2026, iSpecimen Inc. reported a net loss of $5.85 million on revenue of $551,983, a significant decrease from $1.88 million in revenue for the same period in 2025. The company strengthened its balance sheet through PIPE financings totaling $7.5 million and executed a 1-for-40 reverse stock split in April 2026.
- Key figure
- Net loss $2.21M